Skip to Main Content

Paper Details

A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites.
Commun Biol
33
2019
Author NameAffiliation
Marina Wright Muelas1Manchester Institute of Biotechnology and School of Chemistry, The University of Manchester
Philip J R Day7Manchester Institute of Biotechnology and Faculty of Biology, The University of Manchester
Steve O'Hagan1Manchester Institute of Biotechnology and School of Chemistry, The University of Manchester
Douglas B Kell1Manchester Institute of Biotechnology and School of Chemistry, The University of Manchester
  • 1 - 4

Datasets

Release 1.2